Detected ·
Pathos
$237.5MSeries E
Pathos AI closed a $237.5M Series E led by Bristol Myers Squibb, alongside a strategic partnership to scale its Foundry AI platform into oncology and neuroscience (including Alzheimer's), with Tempus AI building the clinical dataset.
- Website
- —
- linkedin.com/company/81971915
- Amount
- $237 500 000 USD
- Stage
- Series E
- Event
- Funding round
- Detected
- 2026-10-24 04:08:14 UTC
- Signal ID
- 75735d4f-fd21-4fa2-9269-323df8bb21a0
As the API returns it
{
"id": "75735d4f-fd21-4fa2-9269-323df8bb21a0",
"created_at": "2026-10-24T04:08:14.068168Z",
"company_name": "Pathos",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/81971915",
"event_type": "funding",
"funding_amount": 237500000,
"funding_currency": "USD",
"funding_stage": "series_e",
"message": "*Pathos AI closed a $237.5M Series E led by Bristol Myers Squibb, alongside a strategic partnership to scale its Foundry AI platform into oncology and neuroscience (including Alzheimer's), with Tempus AI building the clinical dataset.*"
}